Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer

NCT00573131 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00573131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2008
Completion date
November 30, 2010
Enrollment
137 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the esophagus, esophageal cancer, squamous cell carcinoma